Metformin—A Thought-provoking Addition to Anticancer Therapies—Reply
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2022
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Drug Resistance, Neoplasm (MeSH)
- Humans (MeSH)
- Metformin (MeSH)
published in
- JAMA Oncology Journal